Scientific Basis for
Ayurvedic Therapies
edited by
Brahmasree Lakshmi Chandra Mishra
The following instructions are given to
patients to maintain equilibrium of physiological
factors during and after OT:
1. Avoid day sleeping.
2. Avoid a coarse and constipating diet.
3. Drink warm water.
4. Abstain from sexual activities.
5. Suppress normal urges.
6. Avoid speaking loudly.
7. Avoid anger and anxiety.
8. Avoid exposure to heat and cold.
9. Avoid walking in open air.
10. Avoid exercise and hard work.
OT is done to obtain maximum benefit. Either
excess or inadequate oleation may cause
problems. Features of adequate oleation
include improved digestion, lightness of the body,
oiliness of the skin, neuraesthenia,
lethargy, semisolid stool, and visual fat in the stool.
OT is considered inadequate if the patient
passes dry and hard stools and presents with
features like movement of flatus upward
(bumping), weak digestive power, burning
sensation in chest, and dryness of skin.
Features of excessive oleation are heaviness and
stiffness in the body, drowsiness, anorexia,
nausea, dyspepsia, excessive salivation, and
frequent evacuation of mucoid stools.
The possible complications of OT include indigestion,
nausea, anorexia, gastrointestinal
tract upsets, drowsiness, stiffness, skin
diseases, anemia, edema, and piles. These complications
can be easily treated by frequent use of
lukewarm water externally and internally,
with the administration of herbs like Piper longum, Terminalia chebula, Termanalia
belarica,
Emblica officinalis and Comiphora mukul, honey, and symptomatic treatment.
4.2.1.3 Sudation and Fomentation Therapy
(Svedana Karma)4,5
The therapeutic production and induction of
sweat by a variety of methods is termed
sudation therapy (ST). It relieves stiffness,
heaviness, and coldness of the body and induces
sweating. It is administered to liquefy the
oleated toxic materials (brought about by OT),
which are spread throughout the body, and
direct them to the alimentary canal for elimination
by any one of the four cleansing procedures.
ST is administered after OT and it precedes
emesis therapy in the sequence of PKT.
Besides being the principal PREP of PKT, ST
may also be a specific treatment for a number
of disorders, especially in vata-dominant diseases where it may be a main treatment.
4.2.1.3.1 Types of Sudation Therapy
ST may be applied with the use of direct
application of heat (e.g., hot bed, affusion, steam
kettle, sudatorium, etc.) or indirect
application of heat (e.g., exercise, wearing heavy
clothes, exposure to sun rays, etc.). It may
be used on the basis of properties of drug used,
like unctuous or wet ST and dry ST, which are
indicated in vata and kapha-dominant
diseases, respectively. ST may be applied
either to one part of the body as a localized ST
or to the whole body as a generalized ST.
ST is indicated in patients of various types
of paralysis, musculoskeletal disorders,
coryza, cough, stiffness, and need for
undergoing PKT. ST
is contraindicated in patients
© 2004 by CRC Press LLC
Panchakarma Therapy in Ayurvedic Medicine 49
with hemorrhages, diarrhea, eruptive skin
diseases, alcoholism, pregnancy, and in patients
of pitta-dominant
constitution or who are emaciated.
4.2.1.3.2 Procedure of Sudation Therapy
ST must be performed after proper OT. In
localized sudation, steam vapors of decoction
of dashamula (or any other drug) are to be
used on the affected parts. In generalized ST,
medicated vapors are made to pass all over
the oleated patient’s body. ST should be done
for a maximum of 30 to 45 min. Medicated
vapors are generated by boiling the herbs in
water.
The process of ST should be stopped when
sweat appears over the forehead and there
is relief from pain, stiffness, and heaviness.
ST is considered inadequate if the patient does
not produce any sweating and there is no
relief from pain or coldness. A burning sensation
of the body, fainting, vertigo, and
appearance of blisters may occur if ST is done more
than advised.
During and after ST, the blood pressure,
pulse rate, respiratory rate, and temperature
are monitored to make sure they are within
normal limits. Direct exposure to cold water
or cold air should be avoided at least for 1
h, and a bath in lukewarm water is indicated
after ST. Generally, emesis should be given
on the second day after ST and purgation after
about a 3-day interval.
The standard preparations used for ST (for
producing medicated steam) are:
1. Dashamula kwatha (decoction) — Sushruta Samhita Sutra Sthana
39/68–69
2. Rasanasaptaka kwatha (decoction) — CD Amavata– 8
4.2.1.3.2.1 Physical Effects of Sudation
Therapy — Various
procedures of ST therapeutically
induce sweating, which cleanses
microchannels, liquefies toxic materials, and expels
toxic materials along with sweat. It recovers
vascular insufficiency of the joints and muscles
and produces relaxation. These factors might
be responsible for improving blood circulation
and local metabolic processes, causing
relaxation of local structures and producing
relief of local symptoms, functional
recovery, and a slowdown of the disease process being
treated. These therapeutic measures are
classically antivata
and relieve all vata manifestations
and control the disease process. During ST,
the body temperature rises to more than
2 to 3∞C, which results in increased sweating.
4.2.1.3.3 Review of Scientific Data on
Oleation, Massage, and Sudation Therapies6–11
R.H. Singh and G.N. Chaturvedi at Banaras
Hindu University (BHU), Varanasi, studied
the effect of internal oleation
clinically7,10 in patients with hyperchlorhydria and peptic
ulcer after internal administration of dadimadya ghrita as a palliative therapy. They
observed significant clinical improvement in
these patients, including a decrease in gastric
acid secretions and evidence of healing
ulcers confirmed on radiological examinations.
Other researchers also tried internal
oleation with different ghrita preparations
for peptic
ulcers and reported similar observations.11
Scientific studies conducted on the role of
oleation and sudation on a series of patients
of rheumatoid arthritis and other chronic
arthropathies by R.H. Singh at BHU, Varanasi,
are reproduced here.8,9 Similar studies have
been conducted by this author and his team
on rheumatoid arthritis at the National
Institute of Ayurveda, Jaipur, and similar observations
were recorded.6
Another clinical trial tested the role of Pinda Sweda, a type of preparatory procedure, as
a main therapeutic procedure in rheumatoid
arthritis, in which application of oil over the
affected part is followed by fomentation with
a hot rice paste cloth bundle. At the end of
30 days the researchers observed significant
changes in both clinical symptoms, such as
stiffness and pain, as well as in laboratory
tests such as erythrocyte sedimentation rate
and urinary hydroxyproline. Improved
vascularity at the joints was also observed when
the pre- and postangiograms were compared.
4.2.2 Main Cleansing Procedures (Pradhana Karma)
4.2.2.1 Biopurificatory Therapeutic Emesis —
Emesis Therapy (Vamana Karma)12
Emesis therapy (ET) is a process by which the
contents of the stomach including kapha
and pitta dosas are expelled out of body through the mouth. It is one of the MCPs that
eliminates toxic materials from upper parts
of the body.
Herbs used in PKT as emetics are detailed in
Table 4.4.
ET is indicated for patients of asthma,
respiratory disorders, sinusitis, rhinitis, anorexia,
dyspepsia, peptic ulcers, and skin diseases
and in healthy individuals in different states
where kapha dosa is aggravated within normal limits (e.g., in the spring season for
preserving
normal health and preventing diseases). It is
contraindicated in patients of hematemesis,
cardiovascular diseases, and cachexia and in
children and the elderly.
4.2.2.1.1 Procedure of Emesis Therapy
ET is usually the first main procedure of PKT
done after a proper preparation of the body.
After the PREP, OT and ST are done; the
out-of-balance kapha is further increased in the
body by giving oily food, fatty food, animal
meat, milk, and curd for the next 24 h before
the induction of emesis. On the morning of ET
(between 7 and 8 A.M.), a gruel mixed with
ghee in large quantities or 2.5 l of milk or
decoction of Glycerrihza
glabra or sugarcane juice
is given to the patient. After 10 min, emesis
is induced by administering a certain combination
of emetic herbs made into a paste mixed with
ghee. Milk or decoction of Glycerrihza
glabra or sugarcane juice is used as a vehicle to push the paste
down.
TABLE 4.4
Herbs Used in PKT as Emetics
Medicinal Plant Botanical Name
Madanaphala Randia dumatorum
Madhuka Sapotaceae
Kututumbi Lageneria vulgaris
Nimba Azadirachta indica A.
Bimbi Coccinia grandis (l.) Voight
Visala Citrullus colocynthis Schrad
Trapusa Cucumis sativus Linn.
Kutaja Holarrhena antidysenterica Linn.
Murva Celosia cristata Linn.
Devdali Luffa echinata
Vidanga Embelia ribes Burm
Viduli Salix caprea Linn.
Dahana Toddalia asiatica Linn.
Citra Ipomea remiformi Chois
Kosavati Luffa aegyptica Mill-Hock
Karanja Pongamia pinnata Pierre
© 2004 by CRC Press LLC
Panchakarma Therapy in Ayurvedic Medicine 51
Items commonly used in standard preparation
are:
1. Powder seeds of Randia dumatorum (6 to 10 g [4 parts])
2. Powder of Acorus calamus (3 to 5 g [2 parts])
3. Rock salt (3 to 5 g [1 part])
4. Honey (20 ml)
Thoroughly mix the preparations and make them
into a paste. Mix in 100 ml of warm
milk or lukewarm water and ask the patient to
swallow. If the patient is getting an urge
to vomit, instruct him or her to do so. Start
counting the number of bouts of vomiting
and observe its contents.
4.2.2.1.2 Criteria for Proper Emesis Therapy
A bout is the number of times the emetic drug
is vomited out after its administration to
the patient. Adequacy of emesis is assessed
in terms of the number of bouts, ratio of total
output/input, its contents, and signs and
symptoms produced after ET. A proper emesis
will have the sequence of expulsion of
saliva, drug, kapha,
pitta (yellowish bile), and vata
dosa as the end point. The criteria of assessment for effective ET are described
in Table 4.5.
After completing emesis, the patient is asked
to inhale smoke from medicated cigars
prepared with specific drugs that expel
residual dosas, toxic materials, kapha, and unctuousness
in the throat, mouth, nose, and
microchannels. The patient is advised to avoid
speaking loudly, overeating, physical
exertion, anger, and anxiety during and after the
therapy to maintain normal physiology of the
body and avoid complications.
The persistent urge to vomit, heaviness in
the body, itching, and abdominal pain may
occur in the case of an incomplete emesis of
gastric contents. Complications such as
hematemesis, frothy vomiting, fainting,
cardiac pain, clouding of vision, throat pain, and
weakness may occur in uncontrolled excessive
vomiting. The physician should monitor
the subject constantly and stop the whole
process at the right time.
4.2.2.1.3 Review of Scientific Data on Emesis
Therapy
A clinical trial for assessing the role of ET
in 30 patients with bronchial asthma was carried
out by this author and his team on various
scientific parameters. After the completion of
the ET, it was observed that there was
significant improvement in clinical symptoms,
including marked improvement in breath-holding
time, vital capacity, and respiratory
rate. Similarly, statistically significant
changes (p >0.05) were observed in ESR, total serum
proteins, serum electrolytes, lipid profile,
and radiological changes.
TABLE 4.5
Criterion of Assessment of Purification of
the Body by Emesis Therapy
No. Parameters Active Purification
Moderate
Purification Mild Purification
1 No. of bouts 8 6 4
2 Total output and input Output > input
Output > input Output < Input
3 Contents vomited Bile and pitta Bile and pitta Bile and pitta
4 Signs and symptoms To be observed for
adequate emesis
To be observed for
adequate emesis
To be observed for
adequate emesis
All the patients reported relief in heaviness
in the chest, expectoration, cough, breathlessness,
and a feeling of well-being and lightness in
the chest immediately after emesis.
The success rate of ET was approximately 75%
in cases of bronchial asthma.
4.2.2.2 Purificatory Purgation — Purgation
Therapy (Virecana Karma)
Purgation therapy (PT) is a specific process
for elimination of pitta
dosa. PT procedure
involves elimination of pitta dominating dosas and toxins of the body through the rectal
route.
PT is indicated mainly in patients suffering
with hemorrhage from the upper parts of
the body, poisoning, chronic jaundice,
various gastrointestinal tract disturbances, asthma,
skin disorders, epilepsy, insanity, and other
pitta disorders. PT is contraindicated in
patients with anorectal injury, prolapse of
the rectum, bleeding from lower parts of the
body, diarrhea, emaciating chest diseases,
excessive oleation, and after enema. It is also
contraindicated in children, the elderly, and
patients who are weak, tired, have fasted,
pregnent women, or persons desirous of coitus
and pregnancy.
4.2.2.2.1 Procedures of Purgation Therapy
Internal oleation is done prior to PT. A diet
containing fatty materials, liquid, warm/hot
liquid or solid food, and meat soups is given
to the patient. General instructions to be
followed in ET are also to be followed in PT.
The dose of the drug to be administered for
purgation is decided according to both the
nature of the purgative drug and the patient,
as described in Table 4.7. The purgative
recipe is administered at least 2 h after
sunrise (between 7 and 8 A.M.). During PT, the
TABLE 4.6
Herbs Used in PKT as Purgatives
Medicinal Plant Botanical Name
Kutaki Picrorrhiza kurrora
Eranda Ricinus communis
Triphala (haritaki, bibhitaka, amalaki) 3 fruits =
Terminalia chebula, Termanilia belerica, Embelica officenalis
Gavaksi Citrullus colocynthis schrad
Snuhi Euphorbiorbia nerrifolia Linn.
Trivritta Operculina turpenthum
Nilini Indigofera tinctoria Linn.
Tilvaka Locos racemosa roxb.
Aragvadha Cassia fistula Linn.
Kampillaka Mallotus philippinensis
TABLE 4.7
Dose Schedule for Various Purgativesa
No. Drug of Choice Soft Bowel Medium Bowel
Costive Bowel
1 Ricinus communis oil 5–20 ml 20–50 ml 50–100 ml
2 Operculina turpenthum powder 1–3 g 3–6 g 5–10 g
3 Vitis vinifera, cassia fistula,
terminalia chebula decoction
10–20 ml 25–50 ml 50–100 ml
4 Croton tiglium, Euphorbia
neerifolia
60–125 mg 125–250 mg 500–1000 mg
5 Pluntago ovata 3 g 3–6 g 6–12 g
aPurgatives are based on practical
experiences.
stomach should preferably be empty, in
contrast to emesis where the stomach must be
full. Depending on their mode of action and
degree of purgation produced, purgative
drugs may be grouped as mild purgatives
(e.g., Operculina turpenthum root), moderate
purgatives (e.g., Cassia fistula), and drastic purgatives (e.g., Euphorbia nerrifolia milk). Var-
4.2.2.2.2 Criteria for Proper Purgation
Therapy
The patient should be assessed for proper
purgative effect as shown in Table 4.8. A proper
purgation induces a feeling of lightness in
the body and abdomen with improved appetite.
The sequence of expulsion in proper PT is
urine, stool, pitta, drug, kapha,
and vata. If the
patient has dyspepsia, heaviness in the
abdomen or body, vomiting, and constipation, this
suggests inadequate purgation. Signs and
symptoms of excessive purgation include pain
in the abdomen, blood-mixed serous discharge
through the anus, syncope, weakness, and
drowsiness. The physician should constantly
monitor the subject and stop the whole
process at the right time.
4.2.2.2.3 Review of Scientific Data on
Purgation Therapy14–16
A clinical trial for assessing the role of PT
in 30 patients with hepatitis (jaundice) was
carried out by this author and his team on
various scientific parameters. After the completion
of the PT, it was observed that there was
significant improvement in clinical
symptoms such as anorexia, pruritis, nausea,
and abdominal discomforts. There were
significant changes in laboratory tests such
as ESR, 24-h stercobilinogen, and D-xylose
excretion.
All the patients reported relief in the
feeling of lightness in the body and abdomen and
improved appetite. The success rate of PT was
approximately 85% in cases of hepatitis
(jaundice).
After purgation, these patients were put on a
short course of posttherapy dietetic regimen
for 2 to 3 days. Within 7 days after
purgation, these patients showed notable symptomatic
improvement (p < 0.05). The D-xylose excretion test applied on these patients within a
week
of completion of the total procedure showed a
statistically significant (p < 0.001) increase in
D-xylose excretion rate, indicating improved
absorption power, which determines the rate
of purification of microchannels in these
patients.
4.2.2.3 Biopurificatory Therapeutic Enema —
Enema Therapy (Vasti Karma)17
Enema therapy (ENT) is a procedure in which
medicated oils, decoctions, and decoctions
with pastes of herbs or oils are introduced
into the large intestines through the rectum
with the help of an enema apparatus.
TABLE 4.8
Assessing Success of Therapeutic Purgation on
the Basis of Clinical Manifestations
No. Parameters Good Purgation Medium
Purgation Mild Purgation
1 No. of bouts 15–30 10–15 5–10
2 Quantity of feces in
liters
1.5–2 1–1.5 0.05–1
3 Order of contents Mucin/kapha Mucin Mucin
4 Symptoms Signs and symptoms
as per textual
description
Signs and symptoms
as per textual
description
Signs and symptoms
as per textual
description
ious herbs and drugs used in PKT as
purgatives are described in Table 4.6.
4.2.2.3.1 Classification of Enema Therapy
ENT can be classified in different groups on
the basis of drugs that are used in an enema,
such as (1) a decoction-based enema in which
drugs used for the enema contain decoction
in a larger quantity, or (2) an oil-based
enema in which oil is the main ingredient. Usually,
a combination of decoction and oil enema is
given; decoction alone is not indicated at any
time. According to therapeutic actions of the
drugs, the enema can be an oleation enema
that produces oleation of the body, a
roborant enema that improves strength and general
status of health, a purifying enema that
removes toxic materials from the body, or a
depleting enema that reduces fat content of
the body tissue leading to sound health.
ENT may also be classified according to the
number of enemas administered during the
full course of therapy:
1. Karma vasti — Total of 30 enemas, 12 decoction-based and 18 oil-based enemas
administered on alternate days
2. Kala vasti — Total of 16 enemas, 6 decoction-based and 10 oil-based
TABLE 4.9
Herbs Used in PKT to Make Decoctions for
Enema
Medicinal Plant Botanical Name
Madanaphala Randia dumatorum
Kutaja Holarrhena antidysenterica Linn.
Kustha Saussurea costus
Devadali Luffa echinata
Vaca Acorus calamus
Dasmula (group of ten drugs: bilva,
agnimantha, syonaka, kasmarya, patala,
saliparni, prsniparni, brhati, kantakari,
goksura)
Aegle marmelose, Premna integrifolia,
Oroxylum indicum, Gmelina
arboria, Stereospermum suaveolens, Desmodium
gangeticum, Ureria
picta, Solanum indicum, Solanum surrattense,
Tribulus terrestris
Devadaru Cedrus deodaru (Roxb)
Rasna Acampe papillosa
Yava Hordeum vulgare
Methi Foeniculum vulgare Mill
Krtavedhanam Luffa acutangula Roxb
Kulattha Dolichos biflorus Linn.
Saindhava lavan Rock salt
Madhu (honey) Honey
TABLE 4.10
Proposed Quantity of Decoction-Based Enema
According to Various
Age Groups
No. Age
Maximum Quantity of Decoction-Based
Enema
1 1 year 50 ml
2 10 years 400 ml
3 15 years 900 ml
4 18–70 years 1200 ml
5 Above 70 years 1000 ml
Note: The dose of oil-based enema according to age of the patient is recommend.
Examples are Sneha vasti – 300 ml, Anuvasana vasti – 150 ml, and Matra
vasti – 75 ml.
3. Yoga vasti — Total of 8 enemas, 3 decoction-based and 5 oil-based
ENT is indicated in various gastrointestinal
tract disorders, helminthiasis, urogenital
disorders, lithiasis, neuromuscular
disorders, articular diseases, venereal diseases, convulsions
and paralytic disorders, and anorectal
disorders. ENT is contraindicated in patients
with intestinal obstruction, perforation,
ascites, cholera, dysentery, anal inflammation,
anemia, and anasarca.
4.2.2.3.2 Procedure of Enema Therapy
A decoction-based enema is given on an empty
stomach between 5 and 7 P.M. after
subjecting the patient to gentle massage and
mild fomentation. An oil-based enema is
administered 15 to 30 min after having a
light diet in the evening. In both types of ENT,
the quantity of enema is decided according to
the schedule as described in Table 4.11.
Duration of elimination of the enema should
be a maximum of 48 min. If expulsion
does not occur within the stipulated time,
the following complications may occur: tympanitis,
distention of abdomen, painful abdomen, renal
colic, reverse peristalsis, and
pressing pain in the chest region; these
complications should be managed accordingly.
Proper release of fecal matter and flatus, a
feeling of lightness in the abdomen, suggests
proper ENT. It is considered inadequate if
the patient has few urges for evacuation,
gripping pain, flatulence, and dyspnea.
After resting, the patient may take a bath
with warm water. Lukewarm water, milk,
gruel made of rice, meat soup, or another light
diet is given. Excess of physical and mental
exertion is avoided during ENT.
4.2.2.3.3 Uttara Vasti
Uttara vasti is the means by which the drugs of enema are
made to pass through the penis
or vagina or through extra genitalia into the
urinary bladder or uterus. A dose of uttara
vasti is 20 to 40 ml. The remaining description, indications, contraindications,
and mode
of administration of uttara vasti are similar to decoction-based or oil-based
enemas.
4.2.2.3.4 Review of Scientific Data on Enema
Therapy18,19
A clinical trial for evaluating the efficacy
of ENT was conducted on 30 patients with
rheumatoid arthritis with scientific
parameters. Patients were subjected to a course of
Vaitarana vasti (a type of decoction-based enema, Chakradatta, Chapter No. 73/32) for 30
days.
TABLE 4.11
Two Types of Topical Errhines (Nasya)
No. Pratimarsha Nasya (Topical) Marsha
Nasya (Topical)
1 Never produces complications May produce
complications
2 Dose: 2 drops B.D. Dose:
Maximum – 10 drops
Moderate – 8 drops
Minimum – 4 drops
3 Indicated in all seasons and all age groups
Needs consideration of seasons and age
4 Least oleus material used Excess oleus
material used
5 Slow acting and less potent Quick action
and highly potent
Various herbs used in PKT to make decoctions
for enemas are described in Table 4.10.
Significant changes such as stiffness, pain,
and swelling, as well as laboratory tests like
ESR, were observed in both clinical symptoms.
A decrease in the rate of urinary excretion
of hydroxyproline and a trend of restoration
of adrenocortical functions, indicating remission
of the disease process with control of
connective tissue breakdown, were also noted.
After the course of the therapy, patients
showed statistically significant (p <
0.001) increase
in D-xylose excretion rate, indicating
significant improvement in GIT absorption capacity,
clearly indicating the cleansing effect of
microchannels after the MCP (i.e., ENT). Scientific
study on a current series of patients with
rheumatoid arthritis showed relief in symptoms
in 70% of the patients.
4.2.2.4 Errhine Therapy (Nasya Karma)
Errhine therapy (ErT) refers to
administration of medicines in various forms through the
nostrils (i.e., instilling medicated oil in
the nose or administering paste, powder, or fumes
of errhine drugs in the nostrils). There are
two types of ErT: (1) Pratimarsha
nasya and (2)
old. ErT is indicated in various diseases of
the supraclavicular region such as stiff neck
and jaw, headache, migraine, graying of hair,
baldness, facial palsy, aphonia, stammering
or alteration of voice, hoarseness of voice,
corrhyza, tonsillitis, sinusitis, rhinitis, and
earache. ErT should be avoided in patients
who have acute fevers or acute corrhyza or
have had purgation or oleus enema, had
fasted, and had indigestion. There are five
methods of ErT:
1. Inunction (navana)
2. Instillation of nasal drops (avapeedana)
3. Insufflation (dhamapana)
4. Inhalation (dhuma nasya)
5. Topical application (marsha and pratimarsha)
When the oil is being instilled, the head
should not be shaken; the patient should not
loose his or her temper, speak, sneeze, or
laugh. The unctuous material should not be
swallowed and should be expectorated properly
so that no part of it remains inside. The
patient should be instructed to avoid
talking, becoming angry, laughing, and swallowing
of errhine drugs during the ErT procedure.
Standard preparations commonly used for ErT
are listed in Table 4.12, and herbs used
TABLE 4.12
Standard Preparations Commonly Used for
Errhine Therapy
No. Drug Dose (Purification) Reference
1 Anu taila 6 drops in each nostril CSa 5/63–70
2 Rasnadi taila 6 drops in each nostril CCb 26/160
3 Shadbindu taila 6 drops in each nostril BRc 65/83
4 Vyaghhri taila 6 drops in each nostril BR 63/30
5 Pathadi taila 6 drops in each nostril BR 63/29
6 Apamarga taila 6 drops in each nostril BR 65/113
aCS = Charak Sutra.
aCC = Charak Chiikitsa.
cBR = Bhaishajaya Ratnavali.
Marsha nasya (Table 4.11). ErT should be administered to
patients who are 7 to 80 years
in PKT for nasal medication (nasya) are described in Table 4.13. The dose of ErT should
be determined according to Table 4.14.
Adequate ErT produces lightness in the body
and head and sensorial happiness. ErT is
inadequate if the patient has excessive
secretions from the nose, eyes, and mouth and
heaviness in the body. Complications such as
headache, confusion, and salivation may
occur in uncontrolled excessive ErT. The
physician should constantly monitor the subject
to avoid complications.
After ErT; the patient is given mild sudation
over the throat, cheeks, face, and forehead
and a soft massage on the feet, palms, and
back of the neck; hot water gargling of the
mouth and medicated smoking (dhumapana) is advised to the patient to clear the mouth
and throat of residual kapha dosa.
4.2.2.4.1 Review of Scientific Data on
Errhine Therapy20
Clinical efficacy of ErT was evaluated by the
author on 30 patients with chronic sinusitis.
At the end of 21 days, after administration
of ErT with Anu
Taila, the researchers noted
significant changes such as a growing feeling
of well-being, sneezing, nasal secretions,
and headache in both clinical symptoms, as
well as in laboratory findings such as ESR
and radiological findings.
There was a statistically significant (p < 0.001) reduction in TLC and ESR. On radiological
examinations there was a marked reduction in
the haziness of sinuses along with restoration
of normal mucosa. Nasal passages and sinuses
were thoroughly cleansed after a
course of therapy, indicating suppression of
the disease process.
TABLE 4.13
Herbs Used in PKT for Nasal Medication (Nasya)
Medicinal Plant Botanical Name
Vidanga Embelia ribes Burm
Apamarga Achyranthes aspera Linn.
Vyosa (3 pungents: sunthi,
pippali, marica) Zinziber officenalis, Piper longum, Piper
nigrum
Darvi Beriberis aristata
Surala Vateria indica Linn.
Bija of sirisa Albizia lebbek
Brihati Solanum anguivi Lam.
Shigru Moringa oleifera
Madhusarkara Dolichos biflorus Linn.
Saindhava lavana Rock salt
TABLE 4.14
Determination of Dosage in Errhine Therapy
No.
Type of Errhine
Therapy
Mild
Purification
Moderate
Purification
Maximum
Purification
1 Snuffing errhine
therapy
8 drops in each
nostril
16 drops in each
nostril
32 drops in each
nostril
2 Purificatory errhine
therapy
4 drops in each
nostril
6 drops in each nostril 8 drops in each
nostril
3 Blowing errhine
therapy
250 mg 375 mg 500 mg
4 Topical (marsa nasya) 6 drops in each
nostril
8 drops in each nostril 10 drops in each
nostril
5 Topical (pratimarsh
nasya)
2 drops in each
nostril
2 drops in each nostril 2 drops in each
nostril
6 Paste (kalka)
4 drops in each
nostril
6 drops in each nostril 8 drops in each
nostril
7 Smoke (dhumapana) 1–2 min 2–3 min Up to 5 min
© 2004 by CRC Press LLC
58 Scientific Basis for Ayurvedic Therapies
In the author’s clinic, the success rate of
ErT in a current series of patients with chronic
sinusitis is about 90%.
4.2.2.5 Bloodletting Therapy (Rakta Mokshana)
Bloodletting therapy (BLT) may be performed
with or without the help of metallic instruments.
In the latter type, BLT may be administered
by application of leech, cow's horn,
dried bitter gourd, or coupling glass.
BLT is practiced to remove toxic materials in
blood in blood-borne diseases; in pittapredominant
diseases; and also in a few vata disorders like erysepalis, boils and carbuncles,
abscesses, blue and black pigmentation on the
face, moles, eczema, leucoderma and
vitiligo, scabies, red patches, anorectal
inflammation, splenomegaly, jaundice, dyspepsia,
anorexia, stomatitis, halitosis
(foul-smelling mouth), gingivitis, and gout. It is contraindicated
in patients with bleeding disorders, general
anasarca, cachexia, anemia, piles, and
all conditions where venepuncture is
contraindicated.
4.2.2.5.1 Bloodletting Therapy with the
Application of Leeches
The patient should be properly screened
before leech therapy can be given. Before the
BLT is done with a leech, oleation and
sudation should be performed the day before. It
can be done localized or generalized,
depending upon the condition, and the part that is
to be leeched should be dried. Then the
purified leech is applied to the diseased part. The
leech’s mouth is covered with a smooth,
white, moistened cotton swab. When the leech
starts opening its mouth, which is shaped like
a horse's hoof, and raising the shoulders,
the leech is sucking the blood. If the leech
does not start sucking the blood, a drop of milk
or blood is placed over the affected part and
the leech will start sucking the blood. If at
the biting site needling pain and itching
occur, then the leech is sucking pure blood. The
leech is then removed from the site by
pouring rock salt at its mouth. With the removal
of vitiated blood after leech therapy, the
redness and pain subside immediately.
After the leech is detached, the blood from
the sucked area should be allowed to flow
for 1 to 3 min and then dressing either with
turmeric powder and alum powder or
antiseptic solution is applied. Dressing
should be kept in place for 6 to 12 h.
4.2.2.5.2 Bloodletting Therapy by the
Venesection
Venesection is the process of cutting open a
vein under strict aseptic conditions. It is done
with sharp instruments and is a more severe
form of bloodletting than the application of
leeches. When the venesection is done
properly, the blood (which is impure) flows automatically.
Adequate venesection is considered if the
patient feels lightness in the body, a
decrease in pain, and a remission of
symptoms. Signs of inadequate venesection include
swelling, burning sensation, inflammation, pain,
itching, and redness at the site of venesection.
4.2.2.5.3 Bloodletting Therapy by Superficial
Wounding
Superficial incisions are made over the skin
with the help of a scalpel, fine needles, or
instruments under strict aseptic conditions.
BLT with this method is commonly used in
localized blood disorders and in certain skin
disorders. It must be done after taking aseptic
measures. Antiseptic dressing should be
applied over the wound.
BLT improves the collateral circulation of
affected parts and cleanses the microcirculatory
channels directly by removing toxic materials
and exudating from the affected parts.
Hirudin, the chemical substance present in
the saliva of a leech, has a potent anticoagulant
property. It induces bleeding and encourages
free flow of blood, removing the virulent
substances present at the site of the lesion
and helping to restore healthy blood supply.
Hirudin checks the inflammatory process
especially at specific points where bloodletting
is done, which produces rapid symptomatic
improvement.
4.3 Beneficial Effects of Panchakarma Therapy21
The beneficial contribution of PKT is that it
removes the toxic materials from the body
and provides purification of the body at two
levels: (1) the gross level, where various
organs and systems of the body are thoroughly
cleansed (e.g., cardiovascular system,
gastrointestinal tract, chest, etc.); and (2)
the cellular level, where purification and cleansing
of the body is produced at the level of
cells, cell membranes, and molecules. PKT helps
bring the whole body to normalcy; starts
rejuvenation and revitalization of all body tissues;
potentates the pharmacological actions of
various drugs and medicines administered after
PKT; removes waste products, unwanted
materials, various toxins, and stagnant dosas;
and potentiates physiological functions of
all the body systems (e.g., gut absorption
improves considerably and metabolism is also
corrected). The prognosis of various diseases
that are difficult to treat with simple
administration of medicines becomes significantly
improved (good prognosis) after
administration of PKT. PKT not only is a
prerequisite for all the therapeutic
procedures and medications but also has a full therapeutic
role in promoting preventive, curative, and
rehabilitative procedures.
If properly performed, PKT does not produce
any serious complications. If any minor
complications are produced, they are easily
manageable. Specialized techniques of PKT
are simple to perform and can be carried out
at both the outdoor patient and indoor
patient (OPD and IPD) levels. There is no
need to carry out all PKT practices at one sitting;
specific techniques of PKT (any of the MCP)
can be recommended to the patient after
proper preparation. The toxic materials are
eliminated from the body mainly through the
alimentary canal.
4.4 Conclusions
Any type of main cleansing procedure of PKT
is believed to affect the cleansing of
microcirculatory channels by eliminating the
toxic metabolites from the body. This helps
in the process of curing a disease.
Scientific studies indicate that cleansing procedures
appear to help in eradicating chronic
diseases more effectively.
It was observed by the author in a case study
that when PKT was administered as an
adjuvant therapy along with the allopathic
system of medicines, the results were better
than the PKT or allopathic system of
medicines given alone.
Acknowledgments
I am thankful to my co-workers, Dr. Uttam
Sharma, Dr. Sunil Borkar, Dr. Parshuram Yadav,
Dr. Rajesh Gupta, and my son Amit Sharma, for
help in writing this chapter. In addition,
I am extremely thankful to my revered teacher
Prof. R.H. Singh, Dean, Faculty of
Ayurveda, Indian System of Medicine, Banaras
Hindu University, Varanasi, for extending
help and inspiring me to complete this
chapter. I am also thankful to my wife, Dr. (Smt.)
Praveen Sharma, and daughter, Gauri Sharma,
for their help.
References
1. Shri Atri Dev Gupta, Astanga Hrdya, Chaukhamba Sanskrit Sansthana,Varanasi,
India, 1980.
2. Shri Atri Dev Gupta, Astanga Sangrah, Nirnava Sagar Mudranalaya, Bombay, India,
1951.
3. Chaturvedi, G.N. and Shastri, K., Caraka Samhita, Chaukhamba Sanskrit Sansthana,Varanasi,
India, 1979.
4. Haridasa Shridhara Kasture, Ayurvediya Pancakarma Vigyana, Shri Baidya Nath Ayurveda
Bhawana Ltd., Allahabad, India, 1999.
5. Singh, R.H., Panca Karma Therapy, Chaukhamba Sanskrit Series Office,
Varanasi, India, 1992.
6. Singh, D. and Sharma, A.K. (supervisor), A
Clinical Study of Snehana, Svedana and Rasnadi
Gugulu in the Management of Sandhigata Vata
with Special Reference to Osteo Arthritis, M.D.
(Ayurveda) Kayacikitsa thesis, National
Institute of Ayurveda, Jaipur, India, 2000.
7. Chaturvedi, G.N. and Singh, R.H., Studies
on pancha karma therapy. I. Certain physiological
and biochemical studies on snehana and
different types of vasti therapies, Nagarguna, 8(9),
685–691, 1964.
8. Chaturvedi, G.N. and Singh, R.H., Studies
on pancha karma therapy. II. Certain experimental
studies on the effect of svedana in
arthritis, Nagarjuna, 8(10), 767–773, 1964.
9. Chaturvedi, G.N. and Singh, R.H., Studies
on pancha karma therapy. III. A clinical studies on
the treatment of certain neuromuscular and
articular disorders with pinda sweda, Nagarjuna,
8(11), 29–39, 1964.
10. Herron, R.E. and Fagan, J.B.,
Lipophil-mediated reduction of toxicants in humans: an evaluation
of an ayurvedic detoxification procedure,
alternative therapies, 8(5), 40–51, 2002.
11. Singh, R.H. and Chaturvedi, G.N., Studies
on pancha karma therapy. VIII. Therapeutic value
of snehapana in the management of peptic
ulcer syndrome, Nagurjana, 11, 572–578, 1967.
12. Warrier, P.K., Bhattathiri, P.P.N., Radha
Krishnan, P., and Balachandran, K.P., Evaluation of
snehapana in comparison to samana therapy
with mahatikta ghrita in parinamasoola (duodenal
ulcer), J. Res. Ayurveda and Siddha, 8(3–4), 90–105, 1987.
13. Pandey, S.N. and Tripathi, S.N., Studies
on Bronchial Asthma and Samsodhana, M.D. (Ayurveda)
thesis, Banaras Hindu University, Varanasi,
India, 1980.
14. Chaturvedi, G.N. and Singh, R.H., Studies
on pancha karma therapy. IV. Role of pancha karma
therapy in tamaka swasa vis-Ã -vis bronchial
asthma with particular reference to its pathophysiological
basis: a hypothesis, Nagarjuna, 8(2), 119–124, 1964.
15. Singh, R.H. and Singh, R.S.,
Standardisation of vamana and virechana karma, J. Res. Ayurveda
and Siddha, 13(2), 13–27, 1978.
16. Sharma, A. and Sharma, A.K. (supervisor),
Clinical Evaluation of the Role of Samsodhana and
Bhargee Sarkara in the Management of Tamaka
Sawasa (Bronchial Asthma), Ph.D. Kayacikitsa
thesis, National Institute of Ayurveda,
Jaipur, India, 2001.
17. Singh, G. and Chaturvedi, G.N., Studies
on Virecana with Special Reference to Catheritic Effect
of Kutki (Picrorhyza Kurora Royle ex Bigeth),
Ph.D. thesis, Banaras Hindu University, Varanasi,
U.P., 1975
18. Pandey, V.N., Principles of pancakarma
cikitsa, Nagarjuna, 13(10), 23–29, 1970.
19. Gupta, A. and Sharma, A.K. (supervisor),
Study to Evaluate the Efficacy of Vasti Therapy in
Rheumatoid Arthritis (Amavata), M.D.
(Ayurveda) Kayacikitsa thesis, National Institute of
Ayurveda, Jaipur, India, 1999.
20. Mohite, K. and Sharma, A.K. (supervisor),
Clinical Evaluation of Tikta Kshira Vasti in the
Management of Sandhigata Vata with Special
Reference to Osteo Arthritis, M.D. (Ayurveda)
Kayacikitsa thesis, National Institute of
Ayurveda, Jaipur, India, 2000.
21. Rai, R. and Sharma, A.K. (supervisor),
Clinical Evaluation of Nasya Karma in Pinasa Roga
(Pratisayaya), M.D. (Ayurveda) Kayacikitsa
thesis, National Institute of Ayurveda, Jaipur,
India, 2000.
22. Sharma, A.K., Panchakarma Treatment of Ayurveda Including
Keraliya Panchakarma, Sat
Guru
Publications, Delhi, India, 2002.
Om Tat Sat
(Continued...)
(My
humble salutations to H H Maharshi ji, Brahmasri
Sreeman Lakshmi Chandra Mishra ji and other eminent medical scholars and
doctors for the collection)
0 comments:
Post a Comment